参附汤加复方丹参注射液辅助治疗新生儿呼吸窘迫综合征

目的]观察参附汤内服加复方丹参注射液静点辅助治疗新生儿呼吸窘迫综合征的临床效果。方法]将42例呼吸窘迫综合征患儿随机分为两组,对照组21例采用经鼻持续气道正压通气（CPAP）给氧、保暖、保湿、升压、抗菌等综合治疗法;治疗组21例在采用CPAP给氧、保暖、保湿、升压、抗菌治疗的同时,用参附汤煎剂内服加复方丹参注射液静点。治疗7d后,比较治愈率。结果]治疗组存活率95.23%,治愈率71.4%;对照组存活率80.95%,治愈率47.62%。治疗组在临床症状、体征、血气分析及X线检查结果等情况明显优于对照组（P〈0.05）。结论]参附汤内服加复方丹参注射液静点可以帮助改善新生儿呼吸窘迫综合征临床症状和体征,使患儿度过肺泡表面活性物质缺乏期。

New Infants Respiratory Distress Syndrome Treated with Shenfu Decoction and Compound Red Sage Injection in Assistance

Objective] To observe the clinical effect of Shenfu Decoction and Compound Red Sage Injection on new infants respiratory distress syndrome. Method] Randomly divide 42 cases into 2 groups, control group（l） take the integrated therapy： CPAP, oxgen, warming, keeping wet and anti-bacterial; the treatment group（1） take the Shenfu Decoction and Compound Red Sage Injection. Compare their cure rates after 7d. Result] In group 1, survivable rate was 95.23%; cure rate 71.4%; and 80.95% and 47. 62% respectively for other group; the clinical symptoms, signs, blood-gas analysis and X-ray result were all better in group 1 than group 2. Conclusion] Oral taking Shenfu Decoction and Compound Red Sage Injection for vein drip can help relieve infants clinical symptoms and pass alveolus superficial active substance lack period.